10th charity wine tasting in support of research into cancer and metastasis at IRB Barcelona
"Vi per Vida", a charity run by sommelier Xavi Ayala, promotes social awareness of the importance of research.
The event will be held this Sunday, February 25 in Calella.
On Sunday 25 February, the non-profit organisation “Vi per Vida” (Wine for Life), will be holding a new wine-tasting event for 300 people at the Llobet i Gurí Factory in Calella (Barcelona). The objective of this fundraising initiative is to draw public attention to the importance of research and to support research into cancer and metastasis conducted at Institute for Research in Biomedicine (IRB Barcelona). Metastasis is the term used to describe the spread of a primary tumour to distant organs, a process that causes 90% of deaths from cancer
This will be the tenth charity wine-tasting event organised by “Vi per vida”, an initiative run by the sommelier Xavier Ayala and which came about from his passion for wine and the heartfelt death of his father from lung cancer metastasis when Xavier was only nine years old.
"I have always wanted to make support research into metastasis, because of my father. I am very grateful for people’s response and to be able to contribute to strengthening the research conducted by a centre like IRB Barcelona," comments Xavier Ayala.
People interested in attending this event can buy tickets for 10€, which will allow them to taste five wines from various denominations of origin in Catalonia: Alella, Costers del Segre, Catalunya and Empordà.
Furthermore, tickets can be purchased in advance through Ticketea, at the Diagonal de Pineda Restaurant, and at three points of sale in Calella: Fruits secs Tulsà, Sapor d'Italia restaurant and the Bisbe Sivilla Institute.
IRB Barcelona researchers thank the “Vi per Vida” initiative
Related content
News
These proteins are a potential therapeutic target for enhancing the effect of some cancer treatments.
Inhibition of TLK proteins triggers the Alternative Lengthening of Telomeres pathway, a common process in some of the most aggressive types of cancer, such as glioblastoma.
The study, performed by the Genomic Instability and Cancer Laboratory at IRB Barcelona, has been published in the journal Cell Reports.
The mechanism unveiled triggers a mutation fog, causing hundreds of mutations in each tumor, which spread through the genome of lung, head-and-neck and breast cancers.
Researchers from the Genome Data Science Lab have identified the antiviral APOBEC3A enzyme as the major cause of this new type of hypermutation.
Published in Nature Genetics, the study shows how the mutation fog process generates many oncogenic “cancer driver” mutations, thus accelerating tumour development.
Researchers at IRB Barcelona discover a new mechanism in estrogen receptor-positive breast cancer cells.
The inhibition of CPEB2, a key factor in the estrogen signalling pathway, causes cancer cells to proliferate less and protects mice against luminal breast cancer.
- Trustees:
-
- Center:
- A member of:
- Recognised by:
